Postgraduate research degrees
The EGA Institute for Women's Health provides a multi-disciplinary and cross-cutting environment for PhD and MD(Res) students.
Discover our postgraduate research
We offer a dynamic, multidisciplinary environment for PhD and MD(Res) students, with research spanning gynaecological cancer, proteomics, reproductive health, gene and stem cell therapy, prenatal genetics, maternal and fetal medicine, and neonatology
Our programme offers opportunities for graduate study at the forefront of basic science and clinical/translational research within an internationally recognised centre of excellence. It aims to develop both subject-specific and transferable skills, enabling students to contribute meaningfully to the field of women’s health.
In collaboration with the UCL Graduate School, we support the development of critical research, academic, and professional skills to prepare students for a wide range of career paths.
An environment for research and scholarship
The UCL EGA Institute for Women's Health provides research and clinical facilities of high calibre, including access to high-throughput proteomic, genomic, endocrine, cell and molecular laboratories, and clinical and experimental neuro-imaging facilities.
We also have extensive collaborative links with both Physiology and Anatomy. This environment is further enriched by the UCLH Phase 2 Maternity Hospital, opened in 2008, and the location of some research in the UCL Cancer Institute.
About our PhD programme
Our PhD programme aims to develop independent researchers with strong critical thinking, a solid grounding in research methodologies and theory, and transferable skills to advance scientific understanding within the research community
The standard period for a full-time PhD at UCL is three years, with completion within four years at most. Part-time students register for five years and must complete within seven years.
